Fish Skin Disease Market
According to Intent Market Research, the Fish Skin Disease Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 8.5% to touch USD 3.8 billion by 2030. The Fish Skin Disease Market is dominated by key players such as Alltech, Inc., BASF SE, Boehringer Ingelheim, Cargill, Incorporated, Dechra Pharmaceuticals, Elanco Animal Health, Kemin Industries, Kyorin Pharmaceutical Co., Ltd., Merck & Co., Inc., Nutreco N.V., Phibro Animal Health, Vetoquinol S.A. and Zoetis Inc.